SEC 13F Intelligence

Hood River Capital Management LLC / KRYS

Hood River Capital Management LLC’s Krystal Biotech Inc Position

Does Hood River Capital Management LLC own Krystal Biotech Inc (KRYS)? Yes — 619.6K shares worth $160M (+1.60% of its 13F portfolio) as of Q1 2026, up from 613.3K shares the prior filed quarter.

Position Value
$160M
Q1 2026
Shares
619.6K
% of Portfolio
+1.60%
Quarters Held
24
currently held

Position History KRYS

Reported value by quarter
Q2 ’20: $12MQ2 ’20Q3 ’20: $11MQ4 ’20: $16MQ1 ’21: $18MQ1 ’21Q2 ’21: $16MQ3 ’21: $12MQ4 ’21: $16MQ4 ’21Q1 ’22: $26MQ2 ’22: $27MQ3 ’22: $29MQ3 ’22Q4 ’22: $34MQ1 ’23: $36MQ2 ’23: $53MQ2 ’23Q3 ’23: $53MQ4 ’23: $57MQ1 ’24: $88MQ1 ’24Q2 ’24: $96MQ3 ’24: $91MQ4 ’24: $80MQ4 ’24Q1 ’25: $95MQ2 ’25: $73MQ3 ’25: $107MQ3 ’25Q4 ’25: $151MQ1 ’26: $160Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026619.6K$160M+1.60%
Q4 2025613.3K$151M+1.66%
Q3 2025606.9K$107M+1.27%
Q2 2025533.0K$73M+1.02%
Q1 2025524.6K$95M+1.61%
Q4 2024512.7K$80M+1.19%
Q3 2024502.1K$91M+1.48%
Q2 2024521.1K$96M+1.98%
Q1 2024495.6K$88M+1.97%
Q4 2023458.5K$57M+1.56%
Q3 2023460.5K$53M+1.71%
Q2 2023452.5K$53M+1.58%
Q1 2023447.4K$36M+1.16%
Q4 2022426.9K$34M+1.23%
Q3 2022416.8K$29M+1.11%
Q2 2022409.0K$27M+1.07%
Q1 2022384.8K$26M+0.85%
Q4 2021225.7K$16M+0.47%
Q3 2021225.9K$12M+0.36%
Q2 2021234.8K$16M+0.48%
Q1 2021237.9K$18M+0.59%
Q4 2020261.1K$16M+0.52%
Q3 2020257.2K$11M+0.48%
Q2 2020282.2K$12M+0.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hood River Capital Management LLC’s full portfolio or all institutional holders of KRYS.